2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal ...

Why the once-stigmatized treatment is back for women under 60.

A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

Breast cancer is more common after menopause than many realise, and understanding the risks, treatment options, and ...

From pain management to hormone therapy, here are a few ways to address reproductive and sexual issues after cervical cancer treatment.

Maintaining treatment with CDK4/6 inhibitors significantly suppresses the growth of breast cancer cells, even after drug resistance has developed, according to new research.

French lawmakers have voted unanimously to ensure breast cancer patients no longer have to pay out of pocket for the ...

Television actress Chhavi Mittal, who was diagnosed with breast cancer in 2022, slammed a netizen on her social media handle ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...